WithdrawnPhase 1/2

Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks

Stopped: We have decided not to pursue the study

0Started 2009-11

Plain-language summary

The researcher want to improve port wine stain (PWS) therapeutic outcome in response to laser therapy. The researcher want to determine whether the combined use of pulsed dye laser (PDL) therapy and topical tacrolimus or pimecrolimus will improve PWS therapeutic outcome.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 16 years of age and older * Have PWS suitable for comparison testing as determined by the study doctor Exclusion Criteria: * Less than 16 years old * Are pregnant * Have skin cancer * Currently taking immunosuppressive or steroids or photosensitizing drugs * Current participation in any other investigational drug evaluation * Concurrent use of known photosensitizing drugs

What they're measuring

Improve PWS lesion blanching.

Timeframe: 8 weeks

Trial details

NCT IDNCT00969397

SponsorUniversity of California, Irvine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-09

View on ClinicalTrials.gov More Port Wine Stain trials